ctrl K

AI Score

Unlock

Petros Pharmaceuticals In... (PTPI)

AI Score

Unlock

0.05

-0.00 (-2.34%)

At close: Apr 25, 2025, 3:59 PM

0.05

2.19%

After-hours: Apr 25, 2025, 05:30 PM EDT

Petros Pharmaceuticals Revenue Breakdown

Period Ending	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Mar 31, 2023	Sep 30, 2022
Medical Devices Revenue	718.3K	806.45K	775.71K	2.52M	1.01M	682.9K
Medical Devices Revenue Growth	-10.93%	+3.96%	-69.27%	+149.51%	+48.15%	n/a

Revenue by Geography

Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
International Revenue	1.3M	4.8M	6.57M
International Revenue Growth	-73.00%	-26.99%	n/a
United States Revenue	4.53M	n/a	n/a
United States Revenue Growth	n/a	n/a	n/a

Operating Expense Breakdown

Period Ending	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Selling, General, and Administrative Revenue	2.3M	2.29M	2.71M	2.88M	2M	2.25M	2.13M	2.92M	2.17M	3.22M	3.9M	4.18M	3.41M	4.12M	3.88M	3.68M	3.12M	4.06M	4.82M	4.03M	5.63M	5.67M	4.39M
Selling, General, and Administrative Revenue Growth	+0.64%	-15.67%	-5.83%	+43.83%	-11.01%	+5.58%	-27.13%	+34.68%	-32.51%	-17.48%	-6.80%	+22.53%	-17.08%	+6.04%	+5.55%	+17.84%	-23.12%	-15.71%	+19.45%	-28.43%	-0.71%	+29.32%	n/a
Research and Development Revenue	588.36K	368.8K	1.56M	834.33K	389.09K	866.58K	319.09K	177.76K	735.92K	421.24K	405.36K	988.69K	280.58K	500.05K	19.18K	151.84K	36.83K	131.58K	139.38K	n/a	n/a	n/a	n/a
Research and Development Revenue Growth	+59.53%	-76.30%	+86.49%	+114.43%	-55.10%	+171.57%	+79.51%	-75.84%	+74.70%	+3.92%	-59.00%	+252.38%	-43.89%	+2506.99%	-87.37%	+312.29%	-72.01%	-5.60%	n/a	n/a	n/a	n/a	n/a